Dapivirine
CAS No. 244767-67-7
Dapivirine ( TMC120 )
Catalog No. M13709 CAS No. 244767-67-7
Dapivirine (TMC120) is a non-nucleoside inhibitor for HIV reverse transcriptase with IC50 of 24 nM.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 43 | In Stock |
|
5MG | 71 | In Stock |
|
10MG | 104 | In Stock |
|
25MG | 169 | In Stock |
|
50MG | 235 | In Stock |
|
100MG | 318 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDapivirine
-
NoteResearch use only, not for human use.
-
Brief DescriptionDapivirine (TMC120) is a non-nucleoside inhibitor for HIV reverse transcriptase with IC50 of 24 nM.
-
DescriptionDapivirine (TMC120) is a non-nucleoside inhibitor for HIV reverse transcriptase with IC50 of 24 nM, inhibits a broad panel of HIV-1 isolates from different classes, inclucing a wide range of NNRTI-resistant isolates. Phase 3.
-
SynonymsTMC120
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV reverse transcriptase
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number244767-67-7
-
Formula Weight329.40
-
Molecular FormulaC20H19N5
-
Purity>98%(HPLC)
-
SolubilityDMSO: 34 mg/mL (103.21 mM)
-
SMILESN#CC1=CC=C(NC2=NC=CC(NC3=C(C)C=C(C)C=C3C)=N2)C=C1
-
Chemical Name4-[[4-[(2,4,6-Trimethylphenyl)amino]-2-pyrimidinyl]amino]benzonitrile
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Van Herrewege Y, et al. Antimicrob Agents ChemOthers, 2004, 48(1), 337-339.
molnova catalog
related products
-
Delavirdine mesylate
A potent HIV-1 reverse transcriptase inhibitor with IC50 of 0.26 uM for recombinant HIV-1 RT.
-
Limonin
Limonin is a limonoid, and a bitter, white, crystalline substance found in citrus and other plants. It is also known as limonoate D-ring-lactone and limonoic acid di-delta-lactone.
-
BNM-III-170
BNM-III-170 is a small-molecule CD4-mimetic compound that enhances vaccine efficacy against HIV-1 challenge in vivo.